These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31388081)

  • 1. Simultaneous quantification of alpha-aminoadipic semialdehyde, piperideine-6-carboxylate, pipecolic acid and alpha-aminoadipic acid in pyridoxine-dependent epilepsy.
    Xue J; Wang J; Gong P; Wu M; Yang W; Jiang S; Wu Y; Jiang Y; Zhang Y; Yuzyuk T; Li H; Yang Z
    Sci Rep; 2019 Aug; 9(1):11371. PubMed ID: 31388081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel method for simultaneous quantification of alpha-aminoadipic semialdehyde/piperideine-6-carboxylate and pipecolic acid in plasma and urine.
    Yuzyuk T; Liu A; Thomas A; Wilson JE; De Biase I; Longo N; Pasquali M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Apr; 1017-1018():145-152. PubMed ID: 26970849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous determination of alpha-aminoadipic semialdehyde, piperideine-6-carboxylate and pipecolic acid by LC-MS/MS for pyridoxine-dependent seizures and folinic acid-responsive seizures.
    Sadilkova K; Gospe SM; Hahn SH
    J Neurosci Methods; 2009 Oct; 184(1):136-41. PubMed ID: 19631689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effects of a Single Oral Dose of Pyridoxine on Alpha-Aminoadipic Semialdehyde, Piperideine-6-Carboxylate, Pipecolic Acid, and Alpha-Aminoadipic Acid Levels in Pyridoxine-Dependent Epilepsy.
    Wang J; Xue J; Gong P; Wu M; Yang W; Jiang S; Wu Y; Jiang Y; Zhang Y; Yuzyuk T; Li H; Yang Z
    Front Pediatr; 2019; 7():337. PubMed ID: 31508398
    [No Abstract]   [Full Text] [Related]  

  • 5. Preliminary investigation of the use of newborn dried blood spots for screening pyridoxine-dependent epilepsy by LC-MS/MS.
    Jung S; Tran NT; Gospe SM; Hahn SH
    Mol Genet Metab; 2013 Nov; 110(3):237-40. PubMed ID: 23953072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The measurement of urinary Δ¹-piperideine-6-carboxylate, the alter ego of α-aminoadipic semialdehyde, in Antiquitin deficiency.
    Struys EA; Bok LA; Emal D; Houterman S; Willemsen MA; Jakobs C
    J Inherit Metab Dis; 2012 Sep; 35(5):909-16. PubMed ID: 22249334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse lysine catabolism to aminoadipate occurs primarily through the saccharopine pathway; implications for pyridoxine dependent epilepsy (PDE).
    Pena IA; Marques LA; Laranjeira ÂB; Yunes JA; Eberlin MN; MacKenzie A; Arruda P
    Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):121-128. PubMed ID: 27615426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Condensation of delta-1-piperideine-6-carboxylate with ortho-aminobenzaldehyde allows its simple, fast, and inexpensive quantification in the urine of patients with antiquitin deficiency.
    Boehm T; Hubmann H; Petroczi K; Mathis D; Klavins K; Fauler G; Plecko B; Struys E; Jilma B
    J Inherit Metab Dis; 2020 Jul; 43(4):891-900. PubMed ID: 31930735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysine restricted diet for pyridoxine-dependent epilepsy: first evidence and future trials.
    van Karnebeek CD; Hartmann H; Jaggumantri S; Bok LA; Cheng B; Connolly M; Coughlin CR; Das AM; Gospe SM; Jakobs C; van der Lee JH; Mercimek-Mahmutoglu S; Meyer U; Struys E; Sinclair G; Van Hove J; Collet JP; Plecko BR; Stockler S
    Mol Genet Metab; 2012 Nov; 107(3):335-44. PubMed ID: 23022070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dietary lysine restriction and arginine supplementation in two patients with pyridoxine-dependent epilepsy.
    Yuzyuk T; Thomas A; Viau K; Liu A; De Biase I; Botto LD; Pasquali M; Longo N
    Mol Genet Metab; 2016 Jul; 118(3):167-172. PubMed ID: 27324284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal plasma pipecolic acid level in pyridoxine dependent epilepsy due to ALDH7A1 mutations.
    Mercimek-Mahmutoglu S; Donner EJ; Siriwardena K
    Mol Genet Metab; 2013; 110(1-2):197. PubMed ID: 23683770
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of new biomarkers of pyridoxine-dependent epilepsy by GC/MS-based urine metabolomics.
    Kuhara T; Akiyama T; Ohse M; Koike T; Shibasaki J; Imai K; Cooper AL
    Anal Biochem; 2020 Sep; 604():113739. PubMed ID: 32339489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LC-MS/MS method for the differential diagnosis of treatable early onset inherited metabolic epilepsies.
    Mathis D; Beese K; Rüegg C; Plecko B; Hersberger M
    J Inherit Metab Dis; 2020 Sep; 43(5):1102-1111. PubMed ID: 32319100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pipecolic acid elevation in plasma and cerebrospinal fluid of two patients with pyridoxine-dependent epilepsy.
    Plecko B; Stöckler-Ipsiroglu S; Paschke E; Erwa W; Struys EA; Jakobs C
    Ann Neurol; 2000 Jul; 48(1):121-5. PubMed ID: 10894227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysine-restricted diet and mild cerebral serotonin deficiency in a patient with pyridoxine-dependent epilepsy caused by
    Mercimek-Mahmutoglu S; Corderio D; Nagy L; Mutch C; Carter M; Struys E; Kyriakopoulou L
    Mol Genet Metab Rep; 2014; 1():124-128. PubMed ID: 27896080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of urinary alpha-aminoadipic semialdehyde by LC-MS/MS in patients with congenital metabolic diseases.
    Ferrer-López I; Ruiz-Sala P; Merinero B; Pérez-Cerdá C; Ugarte M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 944():141-3. PubMed ID: 24316525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolite Identification Using Infrared Ion Spectroscopy─Novel Biomarkers for Pyridoxine-Dependent Epilepsy.
    van Outersterp RE; Engelke UFH; Merx J; Berden G; Paul M; Thomulka T; Berkessel A; Huigen MCDG; Kluijtmans LAJ; Mecinović J; Rutjes FPJT; van Karnebeek CDM; Wevers RA; Boltje TJ; Coene KLM; Martens J; Oomens J
    Anal Chem; 2021 Nov; 93(46):15340-15348. PubMed ID: 34756024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel biomarker for pyridoxine-dependent epilepsy: Implications for newborn screening.
    Wempe MF; Kumar A; Kumar V; Choi YJ; Swanson MA; Friederich MW; Hyland K; Yue WW; Van Hove JLK; Coughlin CR
    J Inherit Metab Dis; 2019 May; 42(3):565-574. PubMed ID: 30663059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into human lysine degradation pathways with relevance to pyridoxine-dependent epilepsy due to antiquitin deficiency.
    Crowther LM; Mathis D; Poms M; Plecko B
    J Inherit Metab Dis; 2019 Jul; 42(4):620-628. PubMed ID: 30767241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inherited Disorders of Lysine Metabolism: A Review.
    Bouchereau J; Schiff M
    J Nutr; 2020 Oct; 150(Suppl 1):2556S-2560S. PubMed ID: 33000154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.